Table 3.
Clinical outcomes in the two groups
| Outcomes | Observation group (n = 21) | Control group (n = 21) | χ2/t‐value | P‐value |
|---|---|---|---|---|
| VAS | 1.14 ± 0.96 | 1.25 ± 1.12 | 0.342 | 0.734 |
| CMS | 86.00 ± 7.56 | 79.71 ± 9.14 | 2.429 | 0.020 |
| ASES | 87.76 ± 7.15 | 81.62 ± 9.62 | 2.349 | 0.024 |
| DASH | 17.95 ± 7.47 | 28.14 ± 8.27 | 4.190 | <0.001 |
| Complications | 1 | 7 | 3.860 | 0.018 |
Observation group: PHILOS combined with fibular allograft; Control group: PHILOS alone; VAS, Visual Analog Scale; CMS, Constant‐Murley score; ASES, American Shoulder and Elbow Surgeons; DASH, Disability of Arm‐Shoulder‐Hand score.